Dunne Michael W.

CIK 00015535933 companiesMORRISTOWN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001553593

Recent Transactions

50 trades

Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2025-11-18$0.37/sh+6,000→ 241,001 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2025-08-08$0.72/sh+15,000→ 235,001 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2024-08-06+106,247→ 220,001 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+106,247→ 106,247 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Subscription Rights (right to buy)
2024-08-06−212,494→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+106,247→ 106,247 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-12-22$1.40/sh+25,000→ 113,754 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-12-18$1.84/sh+10,000→ 88,754 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-11-22$2.03/sh+20,000→ 78,754 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-10-01−3,487→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-10-01+3,487→ 58,754 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-07-01+1,779→ 55,267 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-07-01−1,779→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-06-15+15,853→ 53,488 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-06-15−15,853→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-04-01+1,299→ 37,635 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-04-01+1,299→ 37,636 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-04-01−1,299→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-01-01+761→ 36,337 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-01-01−761→ 0 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-12-23+3,487→ 3,487 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-09-25+1,779→ 1,779 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-09-07$2.22/sh+10,000→ 35,576 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-25+19,488→ 19,488 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-23−36,798→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-06-23+36,798→ 383,647 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-06-15+237,795→ 237,795 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-03-25−10,494→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-25+10,494→ 346,849 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-03-25+11,426→ 11,426 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-07-25+80,000→ 336,355 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2021-06-23+36,798→ 36,798 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2021-03-25+10,494→ 10,494 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-26$1.73/sh−33,143→ 256,355 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-25+80,000→ 289,498 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2020-10-27+61,540→ 209,498 total
Purchase
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2020-10-27+46,155→ 46,155 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2019-02-15+85,000→ 85,000 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-09-04$10.00/sh+500→ 147,958 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-08-27$10.00/sh+500→ 147,458 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-08-24$10.00/sh+500→ 146,958 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+12,730→ 137,491 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+4,050→ 141,541 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+2,917→ 144,458 total
Conversion
Iterum Therapeutics plc$ITRM
Series A Preferred Shares
2018-05-30−12,730→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−2,917→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−4,050→ 0 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30$13.00/sh+2,000→ 146,458 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2018-05-24+79,567→ 79,567 total
Award
Vaxart, Inc.$VXRT
Stock Option (Right to Buy)
2017-05-18$0.49/sh+20,000→ 75,000 total

Companies

Recent Filings

Address

C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR

MORRISTOWN, NJ, 07960

View on SEC.gov